BioSig Technologies, Inc. (BSGM) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for BSGM is $0.41, representing a -93.3% downside from the current price of $6.1. Price targets range from a low of $0.41 to a high of $0.41.
